In vitro activities of fourteen antimicrobial agents against obligately anaerobic bacteria

被引：19

作者：

Schaumann, R ^{[1
]}

Ackermann, G ^{[1
]}

Pless, B ^{[1
]}

Claros, MC ^{[1
]}

Goldstein, EJC ^{[1
]}

Rodloff, AC ^{[1
]}

机构：

[1] Univ Leipzig, Inst Med Microbiol & Epidemiol Infect Dis, D-04103 Leipzig, Germany

来源：

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2000年 / 16卷 / 03期

关键词：

obligately anaerobic bacteria; antimicrobial agents; broth microdilution technique; MIC;

D O I：

10.1016/S0924-8579(00)00186-2

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

The in vitro activities of fourteen antimicrobial agents were tested against 292 clinical isolates of obligately anaerobic bacteria using the broth microdilution technique. Taking all strains as a group the MIC50/90 (mg/l) values were metronidazole and imipenem 0.25/1, meropenem 0.25/0.5, trovafloxacin 0.25/1, gatifloxacin and moxifloxacin 0.5/2, levofloxacin 2/16, ciprofloxacin 4/32, clindamycin 0.5/8, amoxycillin/clavulanate 1/4, doxycycline and chloramphenicol 2/4, erythromycin 4/ > 32 and penicillin G 16/ > 32. (C) 2000 Elsevier Science B.V. and International Society of Chemotherapy. All rights reserved.

引用

页码：225 / 232

页数：8

共 15 条

[1] Comparative in vitro activities of trovafloxacin (CP 99,219) and other antimicrobials against clinically significant anaerobes [J].

Aldridge, KE ;

Ashcraft, D ;

Bowman, KA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (02) :484-487

[2] Comparison of the in vitro activities of Bay 12-8039, a new quinolone, and other antimicrobials against clinically important anaerobes [J].

Aldridge, KE ;

Ashcraft, DS .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (03) :709-711

[3] Characterization of indole-negative Bacteroides fragilis group species with use of polymerase chain reaction fingerprinting and resistance profiles [J].

Claros, MC ;

Citron, DM ;

Gerardo, SH ;

Goldstein, EJC ;

Schonian, G ;

Montag, T ;

Hampel, B ;

Rodloff, AC .

CLINICAL INFECTIOUS DISEASES, 1996, 23 :S66-S72

[4]

CLAROS MC, IN PRESS ANAEROBE

[5]

*DTSCH I NORM, 1992, MED MIKR IMM NORM WE

[6] Activities of gatifloxacin compared to those of seven other agents against anaerobic organisms [J].

Ednie, LM ;

Jacobs, MR ;

Appelbaum, PC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (09) :2459-2462

[7] Antianaerobic activity of the ketolide RU 64004 compared to activities of four macrolides, five beta-lactams, clindamycin, and metronidazole [J].

Ednie, LM ;

Spangler, SK ;

Jacobs, MR ;

Appelbaum, PC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) :1037-1041

[8] In vitro activity of gemifloxacin (SB 265805) against anaerobes [J].

Goldstein, EJC ;

Citron, DM ;

Warren, Y ;

Tyrrell, K ;

Merriam, CV .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (09) :2231-2235

[9] Bay 12-8039, a new 8-methoxy-quinolone: comparative in-vitro activity with nine other antimicrobials against anaerobic bacteria [J].

MacGowan, AP ;

Bowker, KE ;

Holt, HA ;

Wootton, M ;

Reeves, DS .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (04) :503-509

[10]

*NAT COMM CLIN LAB, 1997, METH ANT SUSC TEST A

← 1 2 →